3 ms·
How about a BBC article that avoids the term, but makes a similar point? https://www.bbc.com/news/health-58270098 https://www.bbc.com/news/health-58270098 > Th
by walterbell 5y ago
How about a BBC article that avoids the term, but makes a similar point? https://www.bbc.com/news/health-58270098 https://www.bbc.com/news/health-58270098
> There is a whole different suite of antibodies (known as immunoglobulin As) in the nose and lungs, compared with those (immunoglobulin Gs) that we measure in the blood. The former is more important as a barrier to infection. Natural infection, because it is in the nose rather than a jab in the arm, may be a better route to those antibodies, and nasal vaccines are being investigated too.
Or a July 2021 paper from academics advising UK SAGE, https://www.gov.uk/government/publications/long-term-evolution-of-sars-cov-2-26-july-2021 https://www.gov.uk/government/publications/long-term-evoluti...
> Whilst we feel that current vaccines are excellent for reducing the risk of hospital admission and disease, we propose that research be focused on vaccines that also induce high and durable levels of mucosal immunity in order to reduce infection of and transmission from vaccinated individuals. This could also reduce the possibility of variant selection in vaccinated individuals.
When a layperson hears the term "immunity", they often equate this term with their experience of a vaccine like the MMR vaccine, which is one and done, rather than monthly reductions of effectiveness, followed by semi-annual boosters. This paper explains one cause of the confusion, i.e. blood/serum vs nose/mucosal immunity, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733922/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733922/
> The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat: the mucosae. As SARS-CoV-2 initially infects the upper respiratory tract, its first interactions with the immune system must occur predominantly at the respiratory mucosal surfaces, during both inductive and effector phases of the response. However, almost all studies of the immune response in COVID-19 have focused exclusively on serum antibodies and systemic cell-mediated immunity including innate responses.
A layperson can understand that a respiratory virus is first encountered in the nose, not their arm muscle.
That's why recovery from Covid nasal infection provides nasal/mucosal immunity (i.e. prevention of infection via defenses in upper respiratory tract) and a muscle-injected vaccine provides symptom reduction after nasal infection, via blood/serum antibodies.
- eesmith 5y agoSure. Are you going to stop using the terms "non-sterilizing vaccine" and "sterilizing vaccine", outside of any publication you may make in a medical journal? > experience of a vaccine like the MMR vaccine, which is one and done No, it absolutely isn't! I have personal experience. I had to get mumps booster shot in college because of a local outbreak. https://www.cdc.gov/mumps/vaccination.html https://www.cdc.gov/mumps/vaccination.html points out under "Mumps Outbreaks Still Occur" that "As most people are not routinely exposed to mumps, there is less immunologic boosting" so "During a mumps outbreak, public health authorities might recommend an additional dose of MMR vaccine for people who belong to groups at increased risk for getting mumps." It also points out that mumps vaccinations require two shots, not "one and done". People are regularly advised to get a tetanus booster every 10 years. Which reminds me, my last one was 10 years ago. And some people get yearly flu shots.